The Caledonian-Record

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...
The Caledonian-Record

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...
Eagle-Tribune

Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
The Business Journals

City Club of Washington closes after nearly four decades

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The club's closure comes as ...